SEC Form 4 · accession 0000899243-18-025553
ARVINAS, INC. · ARVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John G Houston
Officer — President and CEO · Director
Period of report
Sep 26, 2018
Accepted (ET)
Sep 28, 2018 · 8:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001655759
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.00 | Sep 26, 2018 | A | 106,900 | A | — | Sep 25, 2028 | Common Stock | 106,900 | 106,900 | D |
| Stock Option (right to buy)F2 | $16.00 | Sep 26, 2018 | A | 13,360 | A | — | Sep 25, 2028 | Common Stock | 13,360 | 13,360 | D |
| Stock Option (right to buy)F3 | $16.00 | Sep 26, 2018 | A | 13,360 | A | — | Sep 25, 2028 | Common Stock | 13,360 | 13,360 | D |
| Stock Option (right to buy)F4 | $16.00 | Sep 26, 2018 | A | 200,440 | A | — | Sep 25, 2028 | Common Stock | 200,440 | 200,440 | D |
| Stock Option (right to buy)F5 | $16.00 | Sep 26, 2018 | A | 132,880 | A | — | Sep 25, 2028 | Common Stock | 132,880 | 132,880 | D |
Explanation of responses
- F1This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 5, 2018, with the remainder of the shares vesting in equal monthly installments following January 5, 2018 through January 5, 2021.
- F2This option award was granted on September 26, 2018 and will vest upon achievement of a regulatory milestone for the Issuer's androgen receptor program.
- F3This option award was granted on September 26, 2018 and will vest upon achievement of a regulatory milestone for the Issuer's estrogen receptor program.
- F4This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of September 15, 2018, with the remainder of the shares vesting in equal monthly installments following September 15, 2018 through September 15, 2021.
- F5This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.